International Journal of CAR T-Cell Therapy, a peer-reviewed, open access published by Sunvalley Communication, the publisher of ADC Review | Journal of Antibody-drug Conjugates and Onco’Zine, is set to premiere in the Winter of 2025
The International Journal of CAR T-Cell Therapy is an oncology-focused online publication, digital audio (broadcast and podcast), and education platform.
The Journal offers news, opinion, conference coverage, and in-depth interviews with the most highly respected and internationally recognized oncology and hematology experts and Key Opinion Leaders who weigh in on landmark and practice-changing research and trending topics affecting the oncology community.
Submit a Manuscript
Submission of manuscripts and articles for inclusion in the International Journal of CAR T-cell Therapy opens in the summer of 2025. Click on the links for more information:
Advertising and Sponsorship
For publishing, sponsoring or advertising opportunities with International Journal of CAR T-Cell Therapy, contact our sales team via email or click on the link.